It appears that the biopharmaceutical industry is on its way to not only beat but completely demolish prior venture capital fundraising records, based on totals for the first half of 2020 reported in the quarterly Pitchbook-NVCA Venture Monitor, which shows that the biopharma sector raised $12bn during the first half of this year versus $17bn for all of 2019.
Breaking down the numbers in the National Venture Capital Association report produced by the VC-tracking firm Pitchbook, it’s easy to...






